22.1 |
66.4 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
9.9 |
49.3 |
GO:0045989 |
positive regulation of striated muscle contraction(GO:0045989) |
6.2 |
18.5 |
GO:0010837 |
regulation of keratinocyte proliferation(GO:0010837) |
5.5 |
16.6 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
4.3 |
21.4 |
GO:0044854 |
membrane raft assembly(GO:0001765) nitric oxide homeostasis(GO:0033484) negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) membrane assembly(GO:0071709) |
4.0 |
11.9 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
3.0 |
17.7 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
2.4 |
7.2 |
GO:0002124 |
territorial aggressive behavior(GO:0002124) brainstem development(GO:0003360) vocalization behavior(GO:0071625) |
2.2 |
17.9 |
GO:0003065 |
regulation of heart rate by chemical signal(GO:0003062) positive regulation of heart rate by epinephrine(GO:0003065) |
1.9 |
9.7 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
1.9 |
5.8 |
GO:0014028 |
notochord formation(GO:0014028) axial mesoderm morphogenesis(GO:0048319) |
1.7 |
6.8 |
GO:0002689 |
negative regulation of leukocyte chemotaxis(GO:0002689) |
1.6 |
4.7 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
1.2 |
4.7 |
GO:0060209 |
estrus(GO:0060209) |
1.1 |
4.6 |
GO:0009956 |
radial pattern formation(GO:0009956) |
1.1 |
12.5 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
1.1 |
4.4 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
1.0 |
3.0 |
GO:1903115 |
regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.9 |
13.7 |
GO:0034446 |
substrate adhesion-dependent cell spreading(GO:0034446) |
0.9 |
2.7 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
0.9 |
7.7 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.8 |
3.4 |
GO:0043501 |
skeletal muscle adaptation(GO:0043501) |
0.7 |
10.7 |
GO:0035329 |
hippo signaling(GO:0035329) |
0.7 |
2.7 |
GO:0031223 |
auditory behavior(GO:0031223) malate-aspartate shuttle(GO:0043490) |
0.7 |
2.6 |
GO:0030035 |
microspike assembly(GO:0030035) |
0.7 |
3.9 |
GO:2000124 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
0.6 |
5.4 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
0.6 |
3.4 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.5 |
1.6 |
GO:1901142 |
insulin processing(GO:0030070) insulin metabolic process(GO:1901142) |
0.5 |
2.7 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 |
2.6 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
0.4 |
33.7 |
GO:0032387 |
negative regulation of intracellular transport(GO:0032387) |
0.4 |
2.4 |
GO:0010842 |
retina layer formation(GO:0010842) |
0.4 |
3.6 |
GO:0071692 |
sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.4 |
16.0 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
0.4 |
1.9 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) Tie signaling pathway(GO:0048014) |
0.4 |
2.2 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
0.4 |
1.1 |
GO:0007538 |
primary sex determination(GO:0007538) |
0.4 |
3.9 |
GO:0031641 |
regulation of myelination(GO:0031641) |
0.4 |
1.1 |
GO:0021837 |
motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) regulation of mesodermal cell fate specification(GO:0042661) lateral mesoderm development(GO:0048368) lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) regulation of mesoderm development(GO:2000380) |
0.3 |
7.3 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
0.3 |
1.7 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) plasma membrane to endosome transport(GO:0048227) |
0.3 |
18.2 |
GO:0007519 |
skeletal muscle tissue development(GO:0007519) |
0.3 |
2.7 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 |
94.3 |
GO:0006936 |
muscle contraction(GO:0006936) |
0.2 |
3.2 |
GO:0042749 |
regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.2 |
4.8 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
0.2 |
1.4 |
GO:0010766 |
negative regulation of sodium ion transport(GO:0010766) |
0.2 |
4.9 |
GO:0060749 |
mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.2 |
3.5 |
GO:0019220 |
regulation of phosphate metabolic process(GO:0019220) regulation of phosphorylation(GO:0042325) |
0.2 |
0.4 |
GO:0001969 |
activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) positive regulation of activation of membrane attack complex(GO:0001970) positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.2 |
0.8 |
GO:0048261 |
negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.2 |
1.3 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
0.2 |
4.4 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
0.2 |
4.0 |
GO:0030511 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.2 |
3.0 |
GO:0031000 |
response to caffeine(GO:0031000) |
0.2 |
1.4 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
0.2 |
0.2 |
GO:0014742 |
positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.2 |
1.6 |
GO:0070498 |
interleukin-1-mediated signaling pathway(GO:0070498) |
0.2 |
0.5 |
GO:0032571 |
response to vitamin K(GO:0032571) |
0.1 |
0.3 |
GO:0045852 |
integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) positive regulation of integrin biosynthetic process(GO:0045726) pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 |
1.9 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 |
1.4 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
0.1 |
1.3 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 |
5.9 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
0.1 |
1.1 |
GO:0051145 |
smooth muscle cell differentiation(GO:0051145) |
0.1 |
0.2 |
GO:0060457 |
negative regulation of digestive system process(GO:0060457) |
0.1 |
1.1 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 |
16.3 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 |
0.3 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.1 |
2.1 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
0.1 |
1.0 |
GO:0048557 |
embryonic digestive tract morphogenesis(GO:0048557) |
0.1 |
4.1 |
GO:0070374 |
positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.1 |
4.1 |
GO:0008589 |
regulation of smoothened signaling pathway(GO:0008589) |
0.1 |
0.8 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
0.1 |
1.7 |
GO:0050812 |
acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 |
0.4 |
GO:0050686 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.1 |
0.3 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
0.1 |
2.9 |
GO:0035383 |
acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 |
6.9 |
GO:0042035 |
regulation of cytokine biosynthetic process(GO:0042035) |
0.1 |
4.0 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
0.1 |
1.0 |
GO:0006577 |
amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.1 |
0.8 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 |
2.2 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
0.1 |
0.2 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.1 |
0.3 |
GO:0060648 |
nipple development(GO:0060618) mammary gland bud morphogenesis(GO:0060648) mammary gland bud elongation(GO:0060649) nipple morphogenesis(GO:0060658) nipple sheath formation(GO:0060659) |
0.1 |
0.5 |
GO:0006772 |
thiamine metabolic process(GO:0006772) |
0.1 |
0.2 |
GO:0032506 |
barrier septum assembly(GO:0000917) cytokinetic process(GO:0032506) cell septum assembly(GO:0090529) mitotic cytokinetic process(GO:1902410) |
0.1 |
0.3 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 |
1.4 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 |
0.2 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 |
14.3 |
GO:0006184 |
obsolete GTP catabolic process(GO:0006184) |
0.1 |
9.3 |
GO:0006633 |
fatty acid biosynthetic process(GO:0006633) |
0.1 |
0.6 |
GO:0008212 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.1 |
2.4 |
GO:0040014 |
regulation of multicellular organism growth(GO:0040014) |
0.1 |
0.1 |
GO:0061339 |
establishment of apical/basal cell polarity(GO:0035089) establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 |
1.6 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
0.1 |
1.5 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.1 |
17.4 |
GO:0006260 |
DNA replication(GO:0006260) |
0.1 |
1.2 |
GO:0000045 |
autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.1 |
2.0 |
GO:0008633 |
obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.1 |
2.0 |
GO:0051693 |
actin filament capping(GO:0051693) |
0.1 |
0.2 |
GO:0046495 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.1 |
3.2 |
GO:0009408 |
response to heat(GO:0009408) |
0.1 |
0.4 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 |
0.7 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
0.1 |
0.4 |
GO:0002675 |
positive regulation of acute inflammatory response(GO:0002675) |
0.0 |
6.0 |
GO:0032259 |
methylation(GO:0032259) |
0.0 |
1.1 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
0.0 |
0.3 |
GO:0043954 |
cell junction maintenance(GO:0034331) cellular component maintenance(GO:0043954) cell-cell junction maintenance(GO:0045217) |
0.0 |
0.5 |
GO:0045745 |
positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 |
3.9 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
0.0 |
9.9 |
GO:0042493 |
response to drug(GO:0042493) |
0.0 |
5.1 |
GO:0034329 |
cell junction assembly(GO:0034329) |
0.0 |
0.1 |
GO:0060423 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) iris morphogenesis(GO:0061072) cornea development in camera-type eye(GO:0061303) |
0.0 |
0.2 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
0.0 |
0.7 |
GO:0006555 |
methionine metabolic process(GO:0006555) |
0.0 |
1.0 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 |
1.2 |
GO:0060537 |
muscle tissue development(GO:0060537) |
0.0 |
0.1 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
0.0 |
0.5 |
GO:0070509 |
calcium ion import(GO:0070509) |
0.0 |
1.4 |
GO:0051084 |
'de novo' posttranslational protein folding(GO:0051084) |
0.0 |
0.3 |
GO:0008272 |
sulfate transport(GO:0008272) |
0.0 |
0.4 |
GO:0030866 |
cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
0.0 |
0.3 |
GO:0000768 |
syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.0 |
0.4 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
0.0 |
0.2 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
0.0 |
0.3 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
0.0 |
0.2 |
GO:0007204 |
positive regulation of cytosolic calcium ion concentration(GO:0007204) |
0.0 |
2.7 |
GO:0001501 |
skeletal system development(GO:0001501) |
0.0 |
0.1 |
GO:0015695 |
organic cation transport(GO:0015695) |
0.0 |
1.2 |
GO:0007517 |
muscle organ development(GO:0007517) |
0.0 |
0.3 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
0.0 |
0.1 |
GO:0010833 |
telomere maintenance via telomere lengthening(GO:0010833) |
0.0 |
0.2 |
GO:0048015 |
phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.0 |
0.3 |
GO:0008543 |
fibroblast growth factor receptor signaling pathway(GO:0008543) cellular response to fibroblast growth factor stimulus(GO:0044344) response to fibroblast growth factor(GO:0071774) |